XML 16 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Interim Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Total SVBFG Stockholders’ Equity
Noncontrolling Interests
Balance (in shares) at Dec. 31, 2015   51,610,226          
Balance at Dec. 31, 2015 $ 3,333,231 $ 52 $ 1,189,032 $ 1,993,646 $ 15,404 $ 3,198,134 $ 135,097
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)   372,282          
Common stock issued under employee benefit plans, net of restricted stock cancellations 6,852 $ 0 6,852     6,852  
Common stock issued under ESOP (in shares)   43,165          
Common stock issued under ESOP 4,328   4,328     4,328  
Income tax effect from stock options exercised, vesting of restricted stock and other (1) (6,587)   (6,587) [1]     (6,587)  
Net income 170,977     172,138   172,138 (1,161)
Noncontrolling Interest, Period Increase (Decrease) (5,721)           (5,721)
Net change in unrealized gains and losses on AFS securities, net of tax 118,610       118,610 118,610  
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax (2,879)       (2,879) (2,879)  
Foreign currency translation adjustments, net of tax (1,214)       (1,214) (1,214)  
Share-based compensation, net 16,196   16,196     16,196  
Balance (in shares) at Jun. 30, 2016   52,025,673          
Balance at Jun. 30, 2016 3,633,793 $ 52 1,209,821 2,165,784 129,921 3,505,578 128,215
Balance (in shares) at Dec. 31, 2016   52,254,074          
Balance at Dec. 31, 2016 3,777,037 $ 52 1,242,741 2,376,331 23,430 3,642,554 134,483
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)   419,247          
Common stock issued under employee benefit plans, net of restricted stock cancellations 11,822 $ 1 11,821     11,822  
Common stock issued under ESOP (in shares)   10,838          
Common stock issued under ESOP 2,094   2,094     2,094  
Net income 240,396     224,676   224,676 15,720
Noncontrolling Interest, Period Increase (Decrease) (9,603)           (9,603)
Net change in unrealized gains and losses on AFS securities, net of tax (8,047)       (8,047) (8,047)  
Amortization of unrealized gains on securities transferred from AFS to HTM, net of tax (1,994)       (1,994) (1,994)  
Foreign currency translation adjustments, net of tax 1,501       1,501 1,501  
Share-based compensation, net 26,829   26,829     26,829  
Balance (in shares) at Jun. 30, 2017   52,684,159          
Balance at Jun. 30, 2017 $ 4,040,035 $ 53 $ 1,283,485 $ 2,601,007 $ 14,890 $ 3,899,435 $ 140,600
[1] During the first quarter of 2017 we adopted ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. The amendments in this ASU require that all excess tax benefits and tax deficiencies associated with share-based compensation be recognized in income tax expense or benefit in the income statement. Previously, tax effects resulting from changes in the Company's share price subsequent to grant date of share-based compensation awards were recorded through additional paid-in-capital in stockholders' equity at the time of vesting and exercise. This guidance was adopted on a prospective basis with no change to prior period amounts. See Note 1—“Basis of Presentation” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report for additional details.